Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. - Wikidata - awgldk - TriplyDB

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

http://www.wikidata.org/entity/Q34337197

about

The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients Women and Chest Pain: Recognizing the Different Faces of Angina in the Emergency Department Ranolazine: A Contemporary Review Vascular endothelial dysfunction and pharmacological treatment A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve Microvascular angina: angina that predominantly affects women Coronary microvascular dysfunction, microvascular angina, and treatment strategies.Pharmacotherapy for coronary microvascular dysfunction Sex differences in cardiovascular disease - Impact on care and outcomes.Management standards for stable coronary artery disease in India.Management Protocols of stable coronary artery disease in India: Executive summary.Coronary microvascular dysfunction: an update Hypertrophic cardiomyopathy: a review Microvascular coronary dysfunction and ischemic heart disease: where are we in 2014?Endothelial dysfunction and cardiovascular disease.Effect of late sodium current inhibition on MRI measured diastolic dysfunction in aortic stenosis: a pilot study.The Role of Ivabradine in the Management of Angina Pectoris.Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease.Management of microvascular angina pectoris.Treatment of refractory angina in patients not suitable for revascularization.Is there a role for ivabradine beyond its conventional use?Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function A focus on the prognosis and management of ischemic heart disease in patients without evidence of obstructive coronary artery disease.Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.Adaptation of the Coronary Microcirculation in Aging.Coronary endothelial dysfunction in non-obstructive coronary artery disease: Risk, pathogenesis, diagnosis and therapy.Ranolazine and Ivabradine: two different modalities to act against ischemic heart disease.Treatment of Angina Pectoris Associated with Coronary Microvascular Dysfunction.Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update.Ranolazine for stable angina pectoris.Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.Coronary microvascular dysfunction in diabetes mellitus.Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study.Management of stable angina: A commentary on the European Society of Cardiology guidelines.Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial.Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial.

P2860

Q26741956-B62E26F9-30DD-4676-9F61-A8544207742B Q26746172-8B58FFB2-724A-4F2A-8B16-6D1537338448 Q26765421-56BEECB3-7551-4381-A830-7F097752AB74 Q26774561-B7D8D5F9-17A2-4921-ABDD-0F0F077AA93A Q26776330-AF131C2B-FEEE-4C58-8B03-61368D66CB44 Q26860185-07BE6DBB-59A5-4E5C-B82E-3C14A04F89E6 Q26861073-81934C6B-6A3A-4A5F-B74B-A13422A08EAC Q26991627-D848FC12-8A88-4494-8D91-E1B681C9E96D Q30234726-2303BB49-1667-4DFF-9976-55792B9AEB2A Q30239853-5F6552CA-007F-41CA-8ED5-D06453862C43 Q30240155-415949F9-5F30-4EF5-BADD-9EC04989C27D Q34658569-F59143DF-BACA-4FE3-A4C8-456BBA85847F Q35024040-D8A0365A-2B05-441F-8F98-230234C7DF4F Q35108848-43384270-607F-44E7-B324-709B610F2B9A Q35156621-DEFA1392-9237-46D5-B971-E42BB2999E62 Q35915087-81D7ADAF-5CC2-41B9-B010-F70E796179F2 Q37298004-0B83BCE3-508D-48CA-8E17-91B9BC7EDB92 Q37579594-A3BF2896-DBBC-4D12-B17F-FD5A533A0F98 Q38156702-2062EC09-01D1-4340-B46B-A80EC5627425 Q38173640-B6122360-3818-4FFB-9420-45058F7E9CF8 Q38211780-5A4E725D-4373-4E7D-BA48-4C54999AC343 Q38377198-5882C517-22B3-4BC7-BC40-3A91826EF651 Q38574181-17204F55-EE9B-445F-818E-4B52AF2E1D03 Q38663003-C98960DD-D2A8-405B-BD67-4BD1D31BC663 Q38667709-50D944D3-FA17-4FCA-AAE0-44C7E304EDE1 Q38671287-DF0E3679-523D-4134-A013-E3868E2A66D9 Q38761008-B40CA4BB-54E0-4BA7-AB60-3D57C4239FBB Q38846938-886C4AF5-79CD-4C7A-B1FB-294C76D08220 Q38920729-E3A2B088-3442-490F-ACA3-C5887D76B637 Q38971758-36C20DAB-7EFD-4AFD-8633-897DF67261D8 Q39176512-8A63AD38-4A26-48F2-AD1A-8C53F16E2296 Q39393549-5E5FBAB2-01F2-4E9D-888C-19D3ED7EE700 Q39493684-F32A467B-134B-476F-A0FA-40D53AB0E9E1 Q39738089-CB17A98E-5AE9-4E93-BD3D-F5C065C3D0B8 Q42004610-7758DB84-20AC-443B-8F7C-E428F4DD0D5A Q47171821-2DEE5C88-0196-47A0-BA51-A8B3D840E1D9 Q51662386-222A389D-3B6E-4F05-AEBA-1823DCF5562C Q55386798-3AD4BE05-231B-46F2-A0AC-574A0ED8C123

P2860

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

http://www.wikidata.org/entity/Q34337197

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

@ast

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

@en

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

@nl

type

label

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

@ast

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

@en

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

@nl

prefLabel

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

@ast

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

@en

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

@nl

P1433

Q34337197-C1BC188D-BC10-403A-B1CF-B4636281A805

P1476

Q34337197-4CD7D1DB-BE88-4A2E-B74E-29B87BA430E5

P2093

Q34337197-1213D682-7845-47A1-865E-1ECC4D07652C

Q34337197-21716908-2727-4497-B199-A802BFFA2FA2

Q34337197-3B0A4850-3B6B-424D-9B64-3B1923D3E3CD

Q34337197-5689C3E8-53E4-40AC-9B6B-0412404EB8F6

Q34337197-57371F00-F0B1-45CF-B522-A2B1BF06E907

Q34337197-76A7E3BA-C8F6-4AAC-ABFB-2064BAC8FB72

Q34337197-8DDF5EDA-875A-429D-A877-BC721D1216FA

Q34337197-902412E1-4EA6-465E-B705-9921408D1293

Q34337197-C23F0530-1766-4827-A36A-EC70D262CFCF

Q34337197-FA503443-877C-4D39-B95F-490AB778B0E7

P304

Q34337197-D23510A1-1CF7-4F05-A403-D4236D64F913

P31

Q34337197-881B8DF4-2328-46D1-9D1C-B0F9C76BFB65

P356

Q34337197-186D2EEE-2BA6-4652-82A9-FAC7D913FE6A

P407

Q34337197-CF77ED37-43E4-4857-AD66-DC702F0F8D71

P433

Q34337197-88A1289D-23C7-4C88-914B-F7EDF14FD621

P478

Q34337197-EE40B53C-9AA8-4E76-9521-42026F5D3942

P577

Q34337197-4880A280-A58F-4287-B740-1CE9E65DCB98

P5875

Q34337197-9504310E-2C86-4122-8281-C98C9F4BDDA1

P698

Q34337197-BD63DE4E-15D5-47F9-9EED-6A37B98AD6EE

P921

Q34337197-3F5A5F8E-B0E9-4B7A-929A-22B89C2B2A94

P356

J.AMJCARD.2013.02.045

P1433

American Journal of Cardiology

P1476

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

@en

P2093

Alfonso Sestito

http://www.w3.org/2001/XMLSchema#string

Angelo Villano

http://www.w3.org/2001/XMLSchema#string

Antonino Di Franco

http://www.w3.org/2001/XMLSchema#string

Antonio Di Monaco

http://www.w3.org/2001/XMLSchema#string

Filippo Crea

http://www.w3.org/2001/XMLSchema#string

Filippo Maria Sarullo

http://www.w3.org/2001/XMLSchema#string

Gaetano Antonio Lanza

http://www.w3.org/2001/XMLSchema#string

Pierpaolo Tarzia

http://www.w3.org/2001/XMLSchema#string

Priscilla Lamendola

http://www.w3.org/2001/XMLSchema#string

Roberto Nerla

http://www.w3.org/2001/XMLSchema#string

P304

8-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMJCARD.2013.02.045

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236113351

http://www.w3.org/2001/XMLSchema#string

P698

23558043

http://www.w3.org/2001/XMLSchema#string

P921